{
  "pmcid": "12329815",
  "sha256": "eb50d1da043bd8d86facb1ca03ad1d52ba2f0fb5157afc47f1218fb0d04dfee4",
  "timestamp_utc": "2025-11-09T22:21:58.819035+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.624143843772327,
    "reading_ease": 39.609942843534185,
    "word_count": 221
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Intraperitoneal Chemotherapy with Raltitrexed in Stage III Colorectal Cancer"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Patients were randomly assigned to either the observation group, receiving IPC with raltitrexed during laparoscopic radical resection, or the control group, receiving standard surgery without IPC."
      },
      "Participants": {
        "score": 2,
        "evidence": "A total of 195 patients with stage III CRC, aged 18 to 80, were recruited from The First Affiliated Hospital of Wenzhou Medical University between June 2017 and June 2018."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients were randomly assigned to either the observation group, receiving IPC with raltitrexed during laparoscopic radical resection, or the control group, receiving standard surgery without IPC."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the effect of intraperitoneal chemotherapy (IPC) with raltitrexed on survival in patients with stage III colorectal cancer (CRC)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was progression-free survival (PFS), measured from surgery to disease progression or death."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Randomisation and allocation concealment methods were not specified."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not implemented."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Of the 195 patients, 100 were randomised to the observation group and 95 to the control group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on all participants using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The observation group showed significantly improved PFS (χ² = 5.416, p = 0.020) and OS (χ² = 4.673, p = 0.031) compared to the control group."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 15,
    "max_score": 25
  }
}